STAT Plus: New study points to best way to assess which cancer patients immunotherapy will help
APSTOCK
The more mutations tumor cells have, the likelier a patient is to go into remission, and possibly be cured, by checkpoint inhibitors, study finds.


No hay comentarios:
Publicar un comentario